Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed. About 1 in 5 U.S. adults skip filling a prescription due to its cost at least once a ...

Eli Lilly’s decision to pour more than $6 billion into a new pharmaceutical ingredient plant in Huntsville, Alabama, caps a ...

Gemma wrapped up warm in a festive, bright red padded coat, which she teamed with a white fur hat.  She completed her look ...

Meanwhile, the 25-milligram dose of Novo Nordisk's oral semaglutide helped patients lose up to 16.6% of their weight on ...

Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025.

The Coordinating Center, a recognized leader in nonprofit healthcare and person-centered care, and Top Workplace award winner (2025 Baltimore Sun and 2025 Nonprofit Industry Award for the National Top ...

Starting in 2026, people who are insured through Medicare will pay no more than $2,100 out of pocket on prescription drugs over the year. That cap may be much lower than $2,100 due to a quirk in ...

Allink Biotherapeutics, Inc. (AllinkBio), a clinical-stage biotechnology company focusing on developing advanced antibody-drug conjugates (ADCs) and multi-specific antibody therapeutics for oncology ...

The global drug-device combination products market is projected to experience a compound annual growth rate (CAGR) of ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") has approved the Company's ...

ReBoost Nasal Spray has been recalled nationwide after tests found mold and bacteria, prompting FDA warnings of possible ...